When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Achillion Pharmaceuticals (ACHN) made a remarkable recovery in 2019. The stock started the year below $2 per share and traded up to $5 per share last month. I started following the stock this year and wrote two articles on it and my take was that I am interested in the story but neutral on the stock. The stock surged in late July after Achillion reported positive Phase 1 results of ACH-5228, the company's next-gen factor D inhibitor. The reason the stock surged is that ACH-5228 has likely addressed the limitations of danicopan, Achillion’s